A mid-year supply crunch for R-454B refrigerant is forcing hospital facility teams to revise HVAC retrofit schedules and procurement strategies as contractor backlogs, price surges, and federal HFC phase-down deadlines compound the pressure. The shortage, driven by the U.S. EPA's AIM Act compliance mandate effective January 1, 2025, is hitting critical care environments especially hard, where system downtime carries direct clinical risk.
Background
Under the EPA's Technology Transitions Program, manufacturers were prohibited from producing new HVAC equipment using refrigerants with a GWP above 700 beginning January 1, 2025. The rule effectively ended production of R-410A-based systems and established R-454B-a blend of R-32 and R-1234yf with a GWP of 466-as the primary successor refrigerant for the U.S. market. R-454B carries a GWP of 466, approximately 78% lower than R-410A's GWP of 2,088. It is marketed under trade names including Puron Advance and Opteon XL41.
Hospital HVAC systems operate under stricter regulatory requirements than standard commercial buildings. Per CDC and ASHRAE guidelines, operating rooms require a minimum of 20 air changes per hour, MERV 13+ filtration, and precise pressure differentials between zones-requirements that make unplanned downtime during a refrigerant transition both operationally and clinically unacceptable.
Refrigerant management has moved to the forefront of compliance planning for healthcare facilities. According to Trane, which advises healthcare clients on decarbonization, the AIM Act requires an 85% nationwide phase-down of HFC refrigerants in all HVAC systems by 2036. The EPA estimates the shift to next-generation refrigerants will deliver emissions reductions of up to 876 million metric tons of CO₂ equivalent from 2025 through 2050.
Details
Procurement teams sourcing R-454B for hospital retrofits face the same supply bottlenecks affecting the broader HVAC sector, with hospital-specific constraints adding further complexity. In April 2025, Honeywell announced it could no longer keep up with what it described as "unprecedented demand" for R-454B and added a 42% surcharge on the refrigerant to offset raw material import costs. According to industry commentary in ACHR News, the cost of R-454B surged to approximately $60 per pound in 2025, compared to $17 per pound in previous years, while 20-pound cylinders were trading between $650 and $2,000, up from under $200 in 2021.
A key constraint beyond bulk supply is container availability. R-454B's A2L (mildly flammable) classification requires specialized cylinders fitted with a spring safety valve; only one manufacturer globally holds the patent to produce that valve, creating a chokepoint that chemical producers Chemours and Worthington Enterprises have struggled to resolve. According to the Air Conditioning Contractors of America (ACCA), some contractors reported 4- to 8-week backlogs on R-454B installations as of mid-2025.
For hospitals, these delays translate directly into deferred retrofits and extended reliance on aging R-410A equipment that can no longer be replaced with compliant units from the standard supply chain. Facility managers are responding with phased procurement strategies-sequencing replacements unit by unit through non-critical zones first-to preserve system redundancy in ICUs, operating theaters, and isolation wards during transition periods.
A parallel shift is underway in refrigerant selection. R-32, also an A2L-classified refrigerant with a GWP of 675, is readily available through a well-established global supply chain and is used by manufacturers including Daikin, Amana, and Goodman, according to Contracting Business and Facilities Dive. Industry analysts noted that R-32 was available at roughly half the cost of R-454B at the height of the shortage. North America is the only major continent that adopted R-454B as its primary HFC replacement; the rest of the world uses R-32, giving R-32-based systems a substantially more resilient supply chain for facilities seeking to accelerate retrofits without procurement risk.
Manufacturers have taken interim steps to ease installation pressure. According to ACCA's emergency refrigerant forum in May 2025, Trane began pre-loading extra refrigerant charge into vertical discharge units to reduce field top-off requirements, while Hudson Technologies introduced 90-pound cylinder formats as an interim distribution measure. Arkema entered the R-454B market in mid-May 2025 as an additional supplier.
The global hospital HVAC systems market is valued at approximately $12.9 billion in 2025 and is projected to reach $23.2 billion by 2035, growing at a CAGR of 6.0%, according to Fact.MR. Within that market, retrofit projects are outpacing new construction as the near-term driver, particularly in North America, where aging infrastructure and regulatory deadlines are converging.
Outlook
Supply conditions began improving in the second half of 2025. According to HARDI's director of government affairs, distributors reported improved R-454B availability from late August onward as cooling season demand eased, though pricing pressures persisted. The EPA also published a proposed rule on September 30, 2025 that would remove the January 1, 2026 installation deadline for pre-manufactured HFC equipment-a measure that, if finalized, would give hospitals additional flexibility to complete phased retrofits without penalty.
Facility managers and procurement teams planning hospital HVAC replacements into 2026 should evaluate R-32-based system options alongside R-454B equipment, audit existing refrigerant inventories, and sequence retrofit work to protect clinical continuity. Technician certification for A2L refrigerants remains a prerequisite for all fieldwork involving R-454B or R-32 under current EPA and ASHRAE safety standards.
